You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
National Institutes of Health
Health & Research A to Z
Labs & Scientific Resources
News & Events
Health & Research Topics
Skip Website Tools
Email this page
Print this page
Skip Stay Connected
Skip Content Marketing
Autoimmune Lymphoproliferative Syndrome (ALPS)
Molecular Pathways Related to ALPS
Fas and Trail pathways in ALPS
Cell death pathways affected in ALPS
Cell death pathway initiated by Fas ligand (Fas L). Trimeric Fas L binds to the transmembrane protein Fas, inducing trimerization and binding of Fas to FADD. FADD then binds caspase 8, which initiates a proteolytic cascade leading to degradation of DNA and eventual cell death. Recent data indicate that FADD may bind caspase 10 as well. The specific functions of the Fas apoptotic pathway include peripheral deletion of activated T cells following an immune response, cytotoxic T and NK cell mediated killing of virus-infected cells or cancer cells, and killing of inflammatory cells at sites of immune privilege.
Cell death pathways initiated by the ligand TRAIL. Trimeric TRAIL binds to the transmembrane proteins DR4 or DR5, inducing trimerization and binding of DR4 or DR5 to FADD. FADD then preferentially binds caspase 10 (but can bind caspase 8, which initiates a proteolytic cascade leading to degradation of DNA and eventual cell death. The TRAIL pathways can induce T cell death, and recent data indicate they are important in apoptosis of dendritic cells. Although the major function of the TRAIL pathway is induction of apoptosis, it can induce NFkB activation as well.
Back to ALPS portal
Last Updated December 30, 2009
Website Links & Policies
NIAID Employee Emergency Information